Stockscreener 앱 받기
4.67
1.74%
0.08
시간 외 거래:
4.68
0.010
+0.21%
전일 마감가:
$4.59
열려 있는:
$4.64
하루 거래량:
4.45M
Relative Volume:
1.63
시가총액:
$768.74M
수익:
$296.15M
순이익/손실:
$24.02M
주가수익비율:
38.72
EPS:
0.1206
순현금흐름:
$127.01M
1주 성능:
+11.19%
1개월 성능:
+31.92%
6개월 성능:
+126.70%
1년 성능:
+403.40%
1일 변동 폭
$4.555
$4.73
1주일 범위
$4.0802
$4.73
52주 변동 폭
$0.5271
$5.78
아이언우드 제약 Stock (IRWD) Company Profile
명칭
Ironwood Pharmaceuticals Inc
전화
617-621-7722
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
4.67 | 755.58M | 296.15M | 24.02M | 127.01M | 0.1206 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
아이언우드 제약 Stock (IRWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 개시 | Leerink Partners | Market Perform |
| 2024-08-08 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Wells Fargo | Overweight |
| 2023-11-09 | 개시 | Jefferies | Buy |
| 2023-09-28 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-02 | 개시 | CapitalOne | Overweight |
| 2022-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-09-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 개시 | Northland Capital | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | 업그레이드 | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-11-07 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 개시 | H.C. Wainwright | Sell |
| 2018-05-09 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2017-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 개시 | Wells Fargo | Outperform |
| 2017-04-07 | 재확인 | Mizuho | Buy |
| 2017-02-22 | 재확인 | Barclays | Equal Weight |
| 2016-11-04 | 재확인 | Mizuho | Buy |
| 2016-10-24 | 재확인 | Wedbush | Neutral |
| 2016-10-10 | 재확인 | Mizuho | Buy |
| 2016-09-27 | 재확인 | WallachBeth | Hold |
모두보기
아이언우드 제약 주식(IRWD)의 최신 뉴스
Ironwood Pharmaceuticals (IRWD) price target increased by 28.97% to 7.04 - MSN
Ironwood Pharmaceuticals Inc expected to post earnings of 24 cents a shareEarnings Preview - TradingView
Ironwood Pharmaceuticals (IRWD) Highlights Provider Insights on TPN for SBS Treatment - GuruFocus
Why fewer TPN days matter: doctors cite infection, pain in short bowel syndrome - Stock Titan
MSN Money - MSN
Earnings Preview: IRWD to Report Financial Results Pre-market on May 07 - Moomoo
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Press Release: Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - Moomoo
Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - ChartMill
IRWD Technical Analysis | Trend, Signals & Chart Patterns | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharmaceuticals (IRWD) Projected to Post Earnings on Wednesday - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 7.3%Here's What Happened - MarketBeat
[ARS] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan
Ironwood (NASDAQ: IRWD) seeks 10M more equity plan shares in 2026 proxy - Stock Titan
Ironwood Pharmaceuticals (IRWD) price target increased by 10.31% to 5.46 - MSN
Book value per share of Ironwood Pharmaceuticals, Inc. Class A – SWB:I76 - TradingView
Bank of America (NASDAQ: IRWD) reports 6.1% stake in Ironwood Pharmaceuticals - Stock Titan
IRWD Price Today: Ironwood Pharmaceuticals, Inc.Stock Price, Quote & Chart | MEXC - MEXC Exchange
Ironwood (IRWD) to Present Landmark Survey Data at DDW 2026 - GuruFocus
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutritio - PharmiWeb.com
Zacks Research Has Bearish Estimate for IRWD Q2 Earnings - MarketBeat
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 - Yahoo Finance
Zacks Research Issues Positive Outlook for IRWD Earnings - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 6%Here's What Happened - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Update - MarketBeat
Ironwood Pharmaceuticals (IRWD) Stock Put Call Ratio (Momentum Building) 2026-04-15Trading Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 7.8% HigherStill a Buy? - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap UpWhat's Next? - MarketBeat
Ironwood (IRWD) is one of the most attractive small-cap drug manufacturers, here is why - MSN
What events could move Ironwood Pharmaceuticals (IRWD) Stock next | Price at $3.58, Down 1.52%High Yield Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
New Highs: Is Ironwood Pharmaceuticals Inc affected by consumer sentimentM&A Rumor & Consistent Profit Alerts - baoquankhu1.vn
Is trend weakening for Ironwood Pharmaceuticals (IRWD) Stock | Price at $3.46, Down 1.98%Swing Signals - Cổng thông tin điện tử Tỉnh Sơn La
Breakout Move: Will Ironwood Pharmaceuticals Inc outperform the market in YEAR2026 Chart Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Will Ironwood Pharmaceuticals (IRWD) Stock Miss Expectations | IRWD Q4 Earnings: Misses Estimates by $0.02Social Buy Zones - UBND thành phố Hải Phòng
Support Test: Does Ironwood Pharmaceuticals Inc have consistent dividend growth2026 EndofMonth & High Win Rate Trade Tips - baoquankhu1.vn
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.8%Time to Sell? - MarketBeat
아이언우드 제약 (IRWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
2.13%
자본화:
|
볼륨(24시간):